Report #2826146

Received Feb 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 4 yrs
State: TX
Recovered: Unknown
Vaccinated: Jan 16, 2025
Onset: Jan 16, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAPIPV	DTAP + IPV (KINRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	Y498Z	—

Symptoms (1)

Extra dose administered

Symptom narrative

administration of another dose of Kinrix administered on today; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number Y498Z, expiry date 17-MAY-2026) for prophylaxis. Concomitant products included Kinrix. On 16-JAN-2025, the patient received the 2nd dose of Kinrix. On 16-JAN-2025, an unknown time after receiving Kinrix, the patient experienced extra dose administered (Verbatim: administration of another dose of Kinrix administered on today). The outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-JAN-2025 The other health professional reported administration of Kinrix as 5th dose in series and another dose of Kinrix administered on the day of reporting which led to extra dose administered.

Other medications

KINRIX